Clinical trial
A Prospective, Randomized, Double-Blind, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the Z-Lig Medical Device Compared to Allograft for the Reconstruction of Ruptured Anterior Cruciate Ligaments
NCT01245400 is registered in ClinicalTrials.gov with Aperion Biologics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Double-Blind, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the Z-Lig Medical Device Compared to Allograft for the Reconstruction of Ruptured Anterior Cruciate Ligaments
- Lead sponsor
- Aperion Biologics, Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2010
- Completion date
- April 30, 2017
- Enrollment
- 60 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
ruptured anterior cruciate ligaments